Quinapril · 1,331 days since initial FDA posting
Brand: QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE
FDA lists Quinapril as Active Shortage (Aurobindo Pharma USA).
Availability on file: Unavailable
Quinapril/Hydrochlorothiazide Tablet: Active Shortage
Unavailable Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Quinapril/Hydrochlorothiazide Tablet
- Manufacturer
- Aurobindo Pharma USA
- Dosage Form
- Tablet
- Presentation
- Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 65862-161-90)
- Package NDC
- 65862-161-90
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Jan 19, 2023
- Last Updated
- Oct 15, 2025
- Therapeutic Category
- Cardiovascular
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug
Nearby, Other Quinapril/Hydrochlorothiazide Shortage Records
Quinapril/Hydrochlorothiazide Tablet
Aurobindo Pharma USA
Tablet
Quinapril/Hydrochlorothiazide Tablet
Aurobindo Pharma USA
Tablet
Quinapril/Hydrochlorothiazide Tablet
Chartwell Molecular Holdings LLC
Tablet
Quinapril/Hydrochlorothiazide Tablet
Chartwell Molecular Holdings LLC
Tablet
Quinapril/Hydrochlorothiazide Tablet
Chartwell Molecular Holdings LLC
Tablet
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.